Alaunos Therapeutics, Inc.

US$1.74As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TCRTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (46.10%)
Div yield —
ROE (185.95%)
Biotechnology
Beta (5Y) (1.03)
PE TTM —
TSR TTM (36.03%)
Mkt cap US$4.420M
ROIC (117.58%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.80
3.35%
70.58%
Sell 0|8|6|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.04
0.04
(3.08%)
2.62%
17.41%
16.84%
Revenue$M
0.252
0.245
0.246
0.245
10.04%
2.18%
5.29%
0.79%
Peers (US$4.420M)
Cap (US$)
PE
4.439M
—
4.354M
—
Capital
TTM
5Y
10Y
Leveragex
0.861
(0.118)
(0.142)
EBIT/Intx
0.820
0.560
0.425
Own earn%
(43.57)
156.46
153.43
Sh yield%
27.87
14.73
12.55
Owners
Insiders/Inst%
13.08
37.93
Short interest%
4.22
SBC / revenue%
3.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
3–12
$1 testx
—
Incr. ROIC%
8